Disturbances of Modulating Molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA Expressions in the Orbital Tissue from Patients with Severe Graves’ Ophthalmopathy

<div>(a) Strong and diffuse TCR expression in lymphoid cells within the mild Graves ophthalmopathy. Magnification: 100x. (b) Focuses of the lymphoid cells aggregation (TCR expression) in the mild Graves ophthalmopathy. Magnification: 200x. ((c), (d)) Strong and diffuse TCR receptor expression in lymphocytes within severe Graves ophthalmopathy. Magnification: 200x, 100x (the arrows show T cells and fibroblasts).</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: Disturbances of Modulating Molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA Expressions in the Orbital Tissue from Patients with Severe Graves’ Ophthalmopathy 

Figure 1 | Disturbances of Modulating Molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA Expressions in the Orbital Tissue from Patients with Severe Graves’ Ophthalmopathy 